Clinical Trial Update: This is a Post Approval Study of Coaptite® in the Treatment of Female Urinary Incontinence [NA]

View source ↗

Summary

Post-approval study update for Coaptite® in female stress urinary incontinence due to intrinsic sphincter deficiency; study completed with results posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency

Drugs mentioned

• Coaptite

Snippet

Sponsor: Merz North America, Inc. | Conditions: Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency | NA | Status: COMPLETED | Results posted: 2019-07-23